Ipca Laboratories Ltd

NSE: IPCALAB · BSE: 524494 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹1,929.00
Market cap: ₹48,940 Cr
Revenue (annual): ₹9,646 Cr
Net profit (annual): ₹1,141 Cr
P/E (TTM): 37.4×Sector 47.4×
Promoter holding: 44.72%+0.00% QoQ
FII holding: 10.72%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Merger & Restructuring 2 Earnings Call 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Partnership 1 Management Change 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 May 2026 15:07 IST NSE

Management Change

Ipca Laboratories Management Change

Ipca Laboratories approved the re-appointment of Mr. Prashant Godha as Executive Director for five years. The 60-month term begins effective August 16, 2026.

Execution: 60 Months

Read the filing ↗